Fangzhou (6086) Stock Overview
Provides online chronic disease management services in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
6086 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Fangzhou Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.35 |
| 52 Week High | HK$8.18 |
| 52 Week Low | HK$1.60 |
| Beta | 0 |
| 1 Month Change | 20.17% |
| 3 Month Change | 21.17% |
| 1 Year Change | -27.26% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -3.97% |
Recent News & Updates
Shareholder Returns
| 6086 | HK Consumer Retailing | HK Market | |
|---|---|---|---|
| 7D | -10.9% | -1.8% | -1.2% |
| 1Y | -27.3% | 103.4% | 45.2% |
Return vs Industry: 6086 underperformed the Hong Kong Consumer Retailing industry which returned 109.8% over the past year.
Return vs Market: 6086 underperformed the Hong Kong Market which returned 47.1% over the past year.
Price Volatility
| 6086 volatility | |
|---|---|
| 6086 Average Weekly Movement | 8.5% |
| Consumer Retailing Industry Average Movement | 7.7% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.9% |
| 10% least volatile stocks in HK Market | 3.5% |
Stable Share Price: 6086 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 6086's weekly volatility has decreased from 17% to 8% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 485 | Fangmin Xie | Jianke.com |
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content And Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases.
Fangzhou Inc. Fundamentals Summary
| 6086 fundamental statistics | |
|---|---|
| Market cap | HK$5.83b |
| Earnings (TTM) | -HK$25.87m |
| Revenue (TTM) | HK$3.15b |
Is 6086 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6086 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.88b |
| Cost of Revenue | CN¥2.36b |
| Gross Profit | CN¥518.72m |
| Other Expenses | CN¥542.40m |
| Earnings | -CN¥23.68m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.018 |
| Gross Margin | 18.02% |
| Net Profit Margin | -0.82% |
| Debt/Equity Ratio | 0.007% |
How did 6086 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/20 18:36 |
| End of Day Share Price | 2025/09/19 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fangzhou Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ruili Bian | Citigroup Inc |